Notice
- PR information Notice Regarding the Conclusion of an Agreement to Merge Two Wholly Owned Subsidiaries Operating in the Ethical Pharmaceuticals Wholesaling Business Strengthening of Operating Foundations in the Kyushu Area
- PR information Notice Regarding the Strengthening of Strategy Promotion Systems in the Ethical Pharmaceuticals Wholesaling Business
- PR information Notice Regarding the Conclusion of a Basic Agreement Pertaining to the Commercialization of Next-Generation Veterinary Healthcare Platform Between 12 Pharmacy Inc., animo Co., Ltd., and Alfresa Corporation
- PR information Notice Regarding a Verification Test on Improving Dietary Habits Through PHR-Data-Utilizing Product Proposals and Health Support Services Aimed at Extending Healthy Life Expectancies and Preventing Lifestyle-Related Diseases in Tsukuba City
- PR information Notice Regarding the Capital and Business Alliances Between Alfresa Corporation and Ember LifeSciences, Inc. Aimed at Improving Pharmaceutical Cold Chain Transportation Quality
- PR information Notice of the Conclusion of a Basic Agreement on Alfresa Corporation's Assumption of Assets Related to SEGA SAMMY BASEBALL and Preparations for the Establishment of a New Adult Amateur Baseball Club
- PR information Notice Regarding the Capital and Business Alliance Between Alfresa Corporation and eMind, Inc. Aimed at Helping Improve the Quality of Healthcare and Patients' Quality of Life
- PR information Notice Regarding the Joint Establishment of a Working Group Focused on the Clinical Diagnostic Reagents Wholesaling Business by Alfresa Corporation and Seiko CO., LTD
- Others Notice Regarding Certain Alfresa Group Companies Being Recognized as the 2026 Outstanding Organizations of KENKO Investment for Health Program
- PR information Notice Regarding Achievement of ISO 9001 Certification by Subsidiaries: Efforts to Improve Logistics Quality in the Alfresa Group